Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Elvanse

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Pharmacological treatment of the attention-deficit/hyperactivity disorder (ADHD) includes use of the psychostimulant… Expand
Is this relevant?
2018
2018
Amphetamine (AMP) is used as an illicit drug and also for the treatment of attention deficit hyperactivity disorder (ADHD… Expand
Is this relevant?
Review
2018
Review
2018
Lisdexamfetamine dimesylate (lisdexamfetamine; Elvanse®; Tyvense®), an orally-active dexamfetamine prodrug, is indicated in the… Expand
  • table 1
  • figure 1
Is this relevant?
Review
2016
Review
2016
Lisdexamfetamine dimesylate (lisdexamfetamine) is a long-acting amfetamine prodrug with a convenient once-daily oral regimen that… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2015
2015
Lisdexamfetamine is now licensed for use in adults with attention deficit hyperactivity disorder (ADHD) under the brand name… Expand
Is this relevant?
2009
2009
Elvanse 30 mg, 50 mg and 70 mg capsules, hard Lisdexamfetamine dimesylate 
Is this relevant?